Business
2018 Annual Report and Financial Statements
2018 Annual Report and Financial Statements.
About this update from Hvivo Plc
[{"type":"text","content":"\n \nRNS Number : 2431X hVIVO plc 26 April 2019 \n\nhVIVO plc\n(\"hVIVO\" or the \"Company\")\n \n2018 Annual Report and Financial Statements and Annual General Meeting 2019\n \n \nLondon, UK - 26 April 2019: hVIVO plc (AIM: HVO), announces that the following documents have been sent to shareholders.\n \n· Annual Report and Financial Statements for the year ended 31 December 2018\n· Notice of Annual General Meeting (\"AGM\") 2019\n· Form of Proxy for the AGM\n \nIn accordance with AIM Rule 26, these documents are available on Company's website at, http://hvivo.com/investors/financial-reports/.\n \nThe AGM is scheduled to be held at 10.00am BST on Thursday 30 May 2019 on 3rd Floor, Queen Mary BioEnterprises Innovation Centre, 42 New Road, London, E1 2AX.\n \n \nFor further information please contact: \n \n\n\n\nhVIVO plc \n\n\n\n\n\n\n\nTrevor Phillips (Executive Chairman) \n\n\n+44 207 756 1300\n\n\n\n\nShelley Fraser (Finance Director & Company Secretary)\nFleur Wood (EVP, Investor Relations & Communications)\n \n\n\n \n\n\n\n\nNumis Securities Limited\n\n\n +44 207 260 1000 \n\n\n\n\nFreddie Barnfield / Huw Jeremy (Nominated Adviser) \n\n\n\n\n\n\n\nJames Black / Michael Burke (Corporate Broking) \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nFTI Consulting \n\n\n\n\n\n\n\nSimon Conway / Victoria Foster Mitchell \n\n\n+44 203 727 1000\n\n\n\n \n \nNotes to Editors: \nhVIVO plc (\"hVIVO\") is pioneering a human-based clinical trial platform to accelerate drug and vaccine development in respiratory and infectious diseases. Leveraging human disease models in flu, RSV, HRV and respiratory indications, the hVIVO platform captures disease in motion, illuminating the entire disease life cycle from healthy to sick and back to health. Based in the UK, market leader hVIVO has conducted more than 50 clinical studies and inoculated over 2700 volunteers.\n\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@...